SINUS AND EAR PROBLEMS
BIOLOGIC THERAPIES, BALLOON SINUS DILATION AND EUSTACHIAN TUBE DILATION are revolutionary new treatments for sinus and ear conditions with much less downtime, or possibly no surgery at all...
ENT EXPRESS CARE CHECK-IN
THE ENT EXPRESS CARE CLINIC Provides Innovative Medical Care WITH SAME-DAY APPOINTMENTS AVAILABLE WITH OUR HIGHLY SPECIALIZED PHYSICIAN ASSISTANTS For Non-Urgent Ear, Nose & Throat Conditions EVERY FRIDAY From 9am-12pm in the Clayton Office and 2pm-5pm in the Cary Office IF YOU ARE HAVING AN URGENT MEDICAL PROBLEM, PLEASE CALL 911
Sinus Procedures Shown to Reduce Headache and Facial Pain
If you suffer from chronic rhinosinusitis (CRS), you’re likely familiar with the persistent headaches and facial pain that come with it. These symptoms can significantly impact daily life, making it difficult to focus, sleep, and enjoy everyday activities. Fortunately, a recently published study provides promising news. Researchers conducted a systematic review of 26 studies, encompassing
Hearing Aid Use Linked to Lower Dementia and Mortality Risk
A recent study in the United States has brought to light some interesting findings about hearing loss and the use of hearing aids. The study looked at data from 9,885 adults and found that about 14.7% of them had hearing loss. However, only 12.7% of those with hearing loss were regularly using hearing aids. The
Simple In-Office Procedure Mimics Benefit from “Breathe-Right Strips”
A new, minimally invasive in-office procedure using radiofrequency energy to improve nasal airflow is now available at Mann ENT. One version of this procedure is called Vivaer, and is approved by most insurance companies. Mimicking the benefit of “Breathe Right strips”, this 20-minute procedure involves opening up the “nasal valve” which is the narrowed entrance
New In-Office Procedures Provide Long-term Relief of Nasal Airway Blockage, Runny Nose, Congestion, Sneezing, Cough and Nasal Itching
Several new, minimally invasive, in-office procedures that simply heat various internal nasal structures have been shown to provide long-term relief from symptoms of nasal congestion, nasal blockage and runny nose as well as associated symptoms such as cough, sneezing and nasal itching. Simple and safe Radiofrequency energy allows these procedures to be performed under local
New Treatment for Nasal Polyps Improves Sleep Quality
A new medication used at Mann ENT called Dupixent has now been shown to significantly improve sleep quality in patients with chronic sinusitis with nasal polyps. Our doctors have seen excellent results with this new class of Biologic medications, with complete resolution of nasal polyps that in the past have required multiple surgical procedures for
Sublingual Immunotherapy Shows Promise for Asthma Control
A recent study in the Journal of Allergy and Clinical Immunology suggests that sublingual immunotherapy (SLIT) reduces the need for inhaled steroids among patients with mild to moderate allergic asthma. Mann ENT was the first practice in North Carolina to provide sublingual immunotherapy for their patients approximately 15 years ago, and the practice has now
Relief For Scuba Divers with Ear Problems Now Available
A new, minimally invasive office procedure called Eustachian Tube Dilation or Balloon Eustachian Tuboplasty has been helping SCUBA divers with ear pressure problems get back in the water. Many divers know that intense ear pain can accompany deep dives due to the inability to equilibrate air pressure through the eustachian tubes, which are the plumbing
ENT Surgeon Applicants
We are now interviewing Otolaryngology/Head and Neck Surgeons to work at Mann ENT. Click HERE for more information.
Revolutionary New Treatment Now Available for Sinusitis with Nasal Polyps
A new category of therapy is revolutionizing the treatment of advanced sinusitis with nasal polyps at Mann ENT. Known as Biologics, these novel injectable medications have previously provided impressive results for conditions such as allergic asthma and atopic dermatitis, as well as very promising results in treating previously fatal cancers. The FDA has recently approved